CANADA LIFE ASSURANCE Co Increases Holdings in Celsius Holdings, Inc. (NASDAQ:CELH)

CANADA LIFE ASSURANCE Co raised its stake in shares of Celsius Holdings, Inc. (NASDAQ:CELH) by 55.1% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 147,071 shares of the company’s stock after buying an additional 52,238 shares during the quarter. CANADA LIFE ASSURANCE Co owned about 0.06% of Celsius worth $12,186,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. FinTrust Capital Advisors LLC purchased a new position in Celsius in the 1st quarter worth approximately $25,000. Rise Advisors LLC increased its stake in Celsius by 1,370.0% in the first quarter. Rise Advisors LLC now owns 441 shares of the company’s stock valued at $37,000 after acquiring an additional 411 shares during the last quarter. Transcendent Capital Group LLC purchased a new stake in Celsius during the fourth quarter valued at about $25,000. Tidemark LLC purchased a new position in shares of Celsius in the 4th quarter worth about $29,000. Finally, Heritage Wealth Advisors lifted its stake in Celsius by 200.0% in the fourth quarter. Heritage Wealth Advisors now owns 552 shares of the company’s stock worth $30,000 after purchasing an additional 368 shares during the last quarter. 60.95% of the stock is currently owned by institutional investors.

Celsius Price Performance

Shares of CELH stock traded up $1.40 during trading hours on Thursday, reaching $47.04. 3,758,457 shares of the company traded hands, compared to its average volume of 5,110,760. The firm has a 50-day moving average price of $66.51 and a 200 day moving average price of $70.31. The company has a market cap of $10.96 billion, a P/E ratio of 50.15, a P/E/G ratio of 1.46 and a beta of 1.90. Celsius Holdings, Inc. has a 12-month low of $44.81 and a 12-month high of $99.62.

Celsius (NASDAQ:CELH) last posted its quarterly earnings results on Tuesday, May 7th. The company reported $0.27 earnings per share for the quarter, topping analysts’ consensus estimates of $0.20 by $0.07. The business had revenue of $355.70 million during the quarter, compared to analyst estimates of $390.37 million. Celsius had a net margin of 18.63% and a return on equity of 111.29%. The company’s revenue was up 36.9% on a year-over-year basis. During the same period in the prior year, the business posted $0.13 earnings per share. Sell-side analysts predict that Celsius Holdings, Inc. will post 1.05 EPS for the current year.

Insiders Place Their Bets

In other news, Director Hal Kravitz sold 16,500 shares of the business’s stock in a transaction dated Tuesday, May 14th. The stock was sold at an average price of $90.27, for a total value of $1,489,455.00. Following the transaction, the director now directly owns 201,282 shares in the company, valued at $18,169,726.14. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In related news, major shareholder William H. Milmoe sold 40,000 shares of the firm’s stock in a transaction on Friday, May 17th. The shares were sold at an average price of $92.95, for a total value of $3,718,000.00. Following the completion of the transaction, the insider now directly owns 226,245 shares of the company’s stock, valued at $21,029,472.75. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Hal Kravitz sold 16,500 shares of the business’s stock in a transaction dated Tuesday, May 14th. The stock was sold at an average price of $90.27, for a total transaction of $1,489,455.00. Following the completion of the sale, the director now owns 201,282 shares in the company, valued at $18,169,726.14. The disclosure for this sale can be found here. In the last quarter, insiders sold 1,772,617 shares of company stock worth $107,637,044. Corporate insiders own 2.20% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have issued reports on the stock. BNP Paribas initiated coverage on shares of Celsius in a research report on Monday, June 24th. They issued an “outperform” rating and a $87.00 price objective on the stock. Morgan Stanley reissued an “equal weight” rating and issued a $68.00 price target on shares of Celsius in a research note on Tuesday, July 9th. UBS Group cut their price objective on Celsius from $99.00 to $92.00 and set a “buy” rating on the stock in a research report on Wednesday, May 8th. Roth Mkm lowered their target price on Celsius from $87.00 to $75.00 and set a “buy” rating for the company in a research note on Thursday, July 18th. Finally, Bank of America decreased their price objective on Celsius from $84.00 to $60.00 and set a “neutral” rating for the company in a report on Wednesday, July 10th. Three research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $76.51.

Celsius Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.